Jobe, Dean A <br/><br/>
Rapid decline of OspC borreliacidal antibodies following treatment of patients with early Lyme disease.  [electronic resource] 

 -  Clinical and vaccine immunology : CVI  Jun 2011 
 - 1034-7 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1556-679X 
<br/><br/><label>Standard No.: </label>10.1128/CVI.00063-11  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Anti-Bacterial Agents--administration & dosage<br/>Antibodies, Bacterial--blood<br/>Antigens, Bacterial--immunology<br/>Bacterial Outer Membrane Proteins--immunology<br/>Blood Bactericidal Activity<br/>Doxycycline--administration & dosage<br/>Enzyme-Linked Immunosorbent Assay--methods<br/>Humans<br/>Immunoglobulin G--blood<br/>Immunoglobulin M--blood<br/>Lyme Disease--drug therapy<br/>Oligopeptides<br/>Time Factors